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ABSTRACT
The purpose of the present study was to develop a hybrid magnetic resonance/computed tomography (MR/CT)-
compatible phantomand tissue-equivalentmaterials for eachMRandCT image.Therefore, the essential requirements
necessary for the development of a hybrid MR/CT-compatible phantom were determined and the development
process is described. A total of 12 different tissue-equivalent materials for each MR and CT image were developed
from chemical components. The uniformity of each sample was calculated. The developed phantom was designed
to use 14 plugs that contained various tissue-equivalent materials. Measurement using the developed phantom was
performed using a 3.0-T scanner with 32 channels and a SomatomSensation 64. Themaximumpercentage difference
of the signal intensity (SI) value on MR images after adding K2CO3 was 3.31%. Additionally, the uniformity of each
tissue was evaluated by calculating the percent image uniformity (%PIU) of theMR image, which was 82.18±1.87%
with 83% acceptance, and the average circular-shaped regions of interest (ROIs) on CT images for all samples were
within ±5 Hounsfield units (HU). Also, dosimetric evaluation was performed. The percentage differences of each
tissue-equivalent sample for average dose ranged from −0.76 to 0.21%. A hybrid MR/CT-compatible phantom for
MR and CT was investigated as the first trial in this field of radiation oncology and medical physics.
Keywords: magnetic resonance image; computed tomography; magnetic resonance guided radiotherapy; tissue
equivalent; radiation dose calculation
INTRODUCTION
Conventionally, radiation treatment planning uses computed tomogra-
phy (CT) for standard imaging since CT images offer high geometrical
accuracy. The direct connection between the Hounsfield unit (HU)
and electron density information for each tissue for dose calculation
is the ultimate goal of using CT images in radiation treatment planning
[1–3]. However, treatment planning using CT alone is insufficient to
accurately delineate the target volumes of some clinical sites.
The use of magnetic resonance (MR)-only based radiotherapy
with the application of MR images in the radiation treatment planning
process for target delineation has increased because MR images offer
superior soft tissue contrast compared to CT images, especially for
head and neck tumors, prostate cancer, lung tumors and brain lesions;
many studies have been performed with MR-only radiotherapy [4–
12]. However, a critical challenge for MR-only radiation treatment
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image for dose calculation [13–16]. Additionally, utilization of CT for
radiation dose calculation and MR for target delineation are time-
consuming processes with extra costs to acquire multiple images.
Furthermore, image registration accuracy remains a problem when
using MR images for planning radiation treatment [17–19]. With
the increasing challenge of MR image-based radiotherapy, several
approaches have been proposed to resolve the controversial issues
described above, such as the development of multi-modal registration
techniques to reduce registration errors and the generation of pseudo-
CT images to calculate the radiationdose [3, 5–7, 9, 10, 13–18, 20–27].
However, most related studies, in which image registration between
MR and CT images is perfectly performed and conversion of MR
images into CT-like images containing electron density information
is successfully achieved, both MR and CT images are still required
for every patient and demonstrate fractionation during MR-based
radiotherapy because of the lack of electron density information from
MR images.
Most commercial quality assurance (QA) phantoms used in the
radiation oncology field are used for CT calibration and consist of
various tissue- or water-equivalent materials. CT of commercialized
QA phantoms with various tissue-equivalent materials has been uti-
lized to demonstrate the relationship between HU and electron den-
sity to enable the radiation dose to be calculated using a treatment
planning system (TPS). Based on the relationship between HU and
electron density, the HU value on treatment planning CT, usually kilo-
voltage fan-beam CT, is converted into electron density and is then
applied for dose calculation using a TPS. During the installation pro-
cess of each CTmachine and also the commissioning process of a new
TPS in a department of radiation oncology, the relationship between
HU to relative electron density (RED) is generated and adopted into
the TPS. The relationship between RED and HU is considered to
be an important basic parameter for radiation dose calculation even
though large differences and uncertainty in converted RED has little
impact on dose calculation in most of circumstances [28, 29]. Tissue-
equivalent materials for CT images can be easily adopted to develop
QA phantoms because the requirements of tissue-equivalent materials
on CT images aremainly the physical or electron density of eachmate-
rial. These requirements for CT images can be simply adjusted using
materials of various densities. Also, commercialized CT QA phantom
has contained various tissue-equivalent materials and. On the other
hand, productionof tissue-equivalentmaterials onMR images couldbe
challenging compared to producing tissue-equivalent materials on CT
because the principle of MR image acquisition is much more complex
than that of CT image acquisition. Only a few studies have reported
human, tissue-like imaging using in-house phantoms, including tissue-
equivalentmaterials, and tested the developed phantoms using 1.5 and
3.0 T MR [30–33]. In another study, application of tissue-equivalent
materials onMR images for CT image acquisition has been performed
only for evaluating multi-modality image registration techniques with
the purpose of developing adaptiveMR-guided radiation therapy [34].
To the best of our knowledge, other possible applications of those
tissue-equivalent materials in the field of radiation oncology have not
been reported.
We have hypothesized that a single phantom, a hybrid MR/CT-
compatible phantom, used to acquire MR and conventional CT
images can be applied for MR-only radiation treatment and used
for target delineation and radiation dose calculation. Since various
tissue-equivalent samples for each MR and CT image have been
developed and inserted in the hybrid MR/CT-compatible phantom,
the region of interest (ROI) from a single sample on MR and CT
images could represent tissue-equivalent measured data for each
signal intensity (SI) on the MR image and HU on the CT image. In
addition, the relation between the SI and HU from the same sample
image section can be directly applied in a conventional TPS and
workflow. Instead of a CT conversion table in the TPS, the relation
between the SI and HU can be inserted and converted from the SI
on MR to HU on CT or RED. Also, we expect that the developed
phantom could be utilized during the commissioning process for
an MR-only treatment facility and periodical QA in terms of image
values using a density table of CT QA from radiation oncology. Based
on the strategy described above, development of a hybrid MR/CT-
compatible phantom to fully establish MR-only based radiotherapy
was proposed, and its characteristics were determined. Thus, a hybrid
MR/CT-compatible phantom for MR-only based radiation treatment
has been suggested and the tissue-equivalent materials for anMR/CT-
compatible phantom were developed and the results are discussed in
this study.
MATERIALS ANDMETHODS
Requirements of a hybridMR/CT-compatible
phantom
Generally, development of an MR phantom should be given much
more consideration compared to development a CT phantom because
the procedure for MR image acquisition is much more complex than
that for CT image acquisition. In addition, most MR phantoms are
usually filled with water or copper sulfate for image quality control or
MR spectroscopy [35]. However, a MR phantom that can be used in
the radiationoncologyfield is nonexistent, especially for thepurposeof
radiation treatmentplanning and radiationdose calculation.Therefore,
we proposed the following essential requirements of a hybridMR/CT-
compatible phantom: (1) tissue-equivalent relaxation times of theMR
image and HU of the CT image, (2) dielectric properties of MR,
(3) homogeneous relaxation times and HU, (4) sufficient strength
to fabricate a torso, (5) ease of handling, (6) chemical and physical
stability over an extended time and (7) can be used for a wide variety
of tissue-equivalent materials [30–33].
Production of tissue-equivalent materials
onMR and CT images
Several studies have developed various types of production techniques
for tissue-equivalent materials on MR by utilizing various chemical
components for MR-related research. [33] In our study, we followed
a reference study and production technique since this reference
study determined the complex chemical composition required for
tissue-equivalent materials on MR images for various organs in the
human body and because the study has been continuously evaluated
and updated [32, 33]. The results from the reference study are
quantitatively organized, and the chemical components that they used
for most human organs have been reported for over 10 years. One of
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which was blended from various types of seaweed. Carrageenan was
used as a gelling agent to make a rigid gel with sufficient strength to
fabricate a torso with good elasticity. Carrageenan is more resistant
to cracking than agar gel and can be stored for an extended time.
Agaros was used as a T2 modifier, GdCl3 as a T1 modifier, NaN3
as an antiseptic and 3 g of NaN3 was added to each sample except
the ‘Air’ sample. NaN3 is highly soluble in water and very acutely
toxic. NaCl and deionized and distilled water were also used. Most
organs were mimicked in the study. We selectively chose some organs
to be mimicked for MR-only radiation treatment. Table 1, which
includes the group 1 samples, lists the selected organs used in our
study and the amount of each material. Additionally, to emphasize
the advantage of MR-only radiation treatment in terms of soft tissue
contrast, we adopted two different chemical compositions for the liver
and evaluated the possibility of developing tissue-equivalent materials
on each MR and CT image. Based on the group 1 samples, which
consisted of 14 different tissue-equivalent materials, we developed
group2andgroup3.Group2wasdesigned to evaluate the effectiveness
of K2CO3 for MR images (14 samples). Group 3 was designed to
calculate the change inHUonCT images depending on the amount of
K2CO3 (8 samples). The specification of groups 2 and 3 are described
below.
The chemical component K2CO3 was applied to modulate the
physical density according to the HU value on CT in each tissue-
equivalent material because K2CO3 is known to be a component that
does not affect MR images [36]. The effectiveness of K2CO3 on MR
images was tested in our study by calculating the change in SI on MR
images between the same tissue-equivalent material with and without
K2CO3 (group 2). Group 2 consisted of two sets of 7 different tissue-
equivalent materials (muscle, white matter, gray matter, spleen, cervix,
breast glandular, cartilage), and one of the two sets was developed by
adding 15 g of K2CO3. The 7 different tissue-equivalent materials in
group 2 were determined to be as different as the samples of group
1 among the tissue-equivalent materials in the reference study. To
quantitatively evaluate thedifferencebetween thegroup2 sampleswith
and without K2CO3, the percentage change was calculated:
Percentage change =
∣∣∣∣SIwith − SIwithoutSIwithout
∣∣∣∣ × 100 (1)
where SIwith and SIwithout are the average SI in circular-shaped ROI
of three slices of the MR axial plane from each MR set (7 samples
with/without K2CO3, respectively).
Todetermine the amount ofK2CO3 in each tissue-equivalentmate-
rial, the change in HU on CT images depending on the amount of
K2CO3 was calculated using theCT image set of the 8different samples
(group 3). Group 3 consisted of 8 different samples of the same tissue-
equivalent material (breast fat, Table 1), and the amount of K2CO3
varied from 0 to 100 g (0, 10, 20, 40, 60, 90, 100 and 200 g of K2CO3).
Additionally, group 3 was utilized to estimate the effect of K2CO3 on
MR image due to the wide range in the amount of K2CO3 used, unlike
group 2 that contains 15 g. Each sample set was evenly distributed in
the developed phantom to prevent artifacts.
To summarize, each sample grouphasbeendevelopedand specified
according to our purposes. Group 1 demonstrates (i) the composition
of each organ and (ii) the acceptability of our production process by
comparing theT1andT2 relaxation timeswith referencedata aswell as
(iii) the backgroundHU value for each organ sample. Measurement of
the initial HU value for each tissue-equivalent material of group 1 was
performed since the initial HU value required to be modulated using
the relation between HU and the amount of K2CO3, which would be
obtained from the measurement data of group 3. Group 2 was devel-
oped to evaluate the effect of K2CO3 on MR images. As we described
above, the previous group did not utilize K2CO3. Thus, evaluation of
the effect of K2CO3 onMR images was performed usingmeasurement
data of group 2. Finally, group 3was developed to define the amount of
K2CO3 in each sample required to modulate the HU value on CT, and
was also applied to evaluate the effect of a large amount of K2CO3 on
SI onMR images.
The whole process of developing samples is explained in detail in
the reference paper. The mass measurement of each chemical compo-
nent as well as the mixing and cooling processes are described in the
reference paper [37]. The mixing process for each tissue-equivalent
material is crucial since carrageenan and agarose, which are gelling
agents, are difficult to completely mix before the materials solidify.
They can be evenly dissolved at very high temperatures (>100◦C)
[37]. To demonstrate the suitability of our mixing process, the unifor-
mity of each sample was calculated. For each MR image, the percent
image uniformity (%PIU) was calculated for all samples using the
largest square-shapedROI on the sagittal plane [35, 38, 39]. This value
could be interpreted as uniformity in the vertical direction for each









In the selected area, Smin was the minimal SI and Smax was the
maximal SI. The diameter of each ROI was 20 mm and the total num-
ber of pixels in the ROI was 448 for oneMR image slice. Furthermore,
the averageHU in circular-shapedROIs of 7 slices of theCTaxial plane
image was calculated for each sample as an evaluation of uniformity in
the horizontal direction. A difference of±5HU from the average value
was defined as an acceptably produced sample in terms of uniformity
[40] (Fig. 2).
Design of a hybridMR/CT-compatible phantom
The developed phantom was designed to hold 14 plugs (diameter:
37 mm; height: 66 mm for the imaging section, airtight container)
that contained various tissue-equivalent materials on each MR and
CT image. The total height and external diameter were determined
according to the internal size of 8 and 32 channels of the MR head-
coil, respectively. This phantomwas completely watertight, even when
it was laid on its side for further utilization (Fig. 1).
MR and CTmeasurement
Image acquisition using the developed phantom with 14 tissue-
equivalent samples of MR images (group 1) and each test sample
(groups 2 and 3) mentioned above was performed using a 3.0 T
scanner (Achieva Tx 3.0 T, PhilipsMedical Systems, TheNetherlands)
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Fig. 1. The developed phantom (top), geometry of the developed phantom (middle) and the location of the plug in the phantom
(right). Total height and external diameter were decided by the internal size of the 8-channelMRI head-coil. A disk A at both ends
and one disk B in themiddle of the phantom can provide two different interspaces. Seven plugs can be located at one of the
interspaces between disks A and B. Thus, a total of 14 plugs can be inserted into the phantom. The developed phantomwas
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Table 1. Composition of tissue-equivalent materials for each organ for group 1
Organ NaCl [w/w%] Agarose [w/w%] GdCl3 [μmol/kg]
Muscle 0.291 2.076 29.100
White matter 0.031 0.439 77.600
Gray matter 0.199 0.478 14.700
Liver 0.148 1.315 82.900
Liver 0.148 1.759 84.100
Kidney 0.383 0.981 43.100
Heart 0.323 1.294 27.200
Prostate 0.291 0.714 22.200
Spinal cord 0.039 0.529 59.300
Bone marrow 0.000 0.868 127.700
Breast fat 0.000 0.340 209.400
Pancreas 0.291 1.220 97.600
Air 0.000 0.000 0.000
Water 0.000 0.000 0.000
Table 2. Signal intensity onMR images of various tissue-equivalent materials (group 2)
Organ Signal intensity
With K2CO3 Without K2CO3 Percentage change
Muscle 1161.45 1130.24 2.8%
White matter 1459.60 1429.54 2.1%
Gray matter 1305.65 1267.97 3.0%
Spleen 1314.30 1285.54 2.2%
Cervix 1244.69 1204.76 3.3%
Breast glandular 1145.79 1139.33 0.6%
Cartilage 1247.81 1213.75 2.8%
CT scanner (Somatom Sensation 64, Siemens Medical Solutions,
Forchheim, Germany). The MR image scan parameters for the axial
plane were as follows: slice thickness, 10 mm; matrix, 256× 256; field
of view, 220mm;bandwidth,±15.63 kHz; andnumber of acquisitions,
1. The saturation recovery method with a constant TE value of 15 ms
was applied for theT1measurement (TR:133, 167, 217, 300, 400, 533,
717, 950, 1683, 3000, 5283, 9317 ms). For the T2 measurement, the
spin echo method with a constant TR value of 10 000 ms was applied
(TE: 15, 22, 29, 39, 52, 69, 93, 125, 167, 224, 300 ms). The sagittal
plane of the MR image for the uniformity check of the samples of
groups 2 and 3 was acquired using the same scan parameters discussed
above with spin echo (fast spin echo, Achieva Tx 3.0 T, PhilipsMedical
Systems, The Netherlands) T2-weighted image TR 15 000 ms and TE
15 ms. The developed phantom was scanned using a CT simulator
with a slice thickness of 3 mm and at 120 kVp, 200 mAs, a 50 cm field
of view, and a 512 512 image matrix, which resulted in a voxel size of
0.9766× 0.9766× 3 mm3 using an axial acquisition.
Dosimetric evaluation
After the development of phantom and tissue-equivalent materials
both on CT and MR, T1, T2 measurement of each sample and eval-
uation of the effect on K2CO3 on the MR and CT images, dosimetric
evaluation was conducted using various types of samples on CT and
MR images. The CT andMR image from group 1 was applied for dosi-
metric evaluation.Dose distribution from theCT image of group 1was
utilized as reference data, and dosimetric results from the converted
MR image set were imported to a commercialized treatment planning
system (RayStation 5 SP3 (5.0.3.17), RaySearch Laboratories, Stock-
holm, Sweden) and converted to a CT-like image. Dose calculation
using the collapsed cone algorithm (Version 3.2) in RayStation was
performed by applying 500 cGy on the isocenter of the 6 MV photon
for SSD (source to surface distance) 90 cm and 30 x 30 cm2 fields with
0◦ of gantry angle and the isocenter was the center coordinate of the
phantom external ROI.
RESULTS
Measurement forMR and CT
Table 1 lists the selected organs and amount of each chemical compo-
nent required for the production of tissue-equivalent materials. Based
on the materials described in Table 1, various tissue-equivalent mate-
rials, which were defined in group 1, were produced to evaluate the
potential of conversion of the SI on MR into HU on the CT image. A
fitted curve using the measured HU values from group 3, which was
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Fig. 2. Schema of the calculation process for percent image
uniformity on anMR image. The red line (left) was the selected
slices in theMR image to calculate percentage image
uniformity (%PIU) and the number (1–7) on each circular
shaped region of interest (ROI) indicates each plug with the
axial view. The gray rectangle (right, 1–7) indicates the sagittal
plane of each plug on theMR image at the selected slice. The
selected ROI of theMR image was applied to calculate the
signal intensity for minimum andmaximum value (Smin, Smax)
and those values were utilized for calculation of %PIU.
HU on CT, is shown in Fig. 3. From the calculated HU shown in Fig.
3, the formula to modulate HU for tissue-equivalent materials on CT
images is described below
HU = 4.692 × K2CO3(g) + 3.81 (3)
Themeasured SI fromMR for group 2, whichwas designed to eval-
uate the effectiveness of K2CO3, is shown in Table 2. The maximum
percentage difference was 3.31% and the minimum percentage differ-
ence was 0.57%. Also, the additional experiment for SI measurement
using group3,which consistedof 8different samples of the same tissue-
equivalent material (breast fat, Table 1) with the amount of K2CO3
varying from0 to 100 g (0, 10, 20, 40, 60, 90, 100 g of K2CO3), showed
that the maximum percentage difference was 2.75%. The HU, SI and
T1 and T2 relaxation times of each tissue-equivalent material listed in
Table 1 are shown in Table 3. The differences between the reference
data and our measurement data for the T1 and T2 relaxation times
were calculated, and the averages of the percentage differences were
0.37 and 5.98% for the T1 and T2 relaxation times, respectively. Also,
the initialHUvalue of each tissue-equivalentmaterial on theMR image
was calculated as shown in Table 3. Based on this initial HU value, the
appropriate HU of each tissue-equivalent material on the CT image
could be produced by considering equation (2).
Production of tissue -equivalent materials
The uniformity of each tissuewas evaluated by calculating the%PIUof
theMR image and the average and standard deviation of the CT image
for all sample images. The %PIU of 83% of the acceptance value for
theMR image was 82.18%± 1.87 [35,38,39]. The average of circular-
shaped ROIs on the CT image for all sample was within±5HUwhich
was the constraint value to evaluate the uniformity of a mixed sample
[40]. The durability of the inserted material could be tested since the
result was consistent over 4months. However, each plug that was filled
with tissue-equivalent material should be sealed right after the cooling
process since the material dries out rapidly. The shape of the solidified
material in each plug changes if the caps are not sealed. The end of the
cooling process can be seen from the changed color of each material
Fig. 3. Relation between the amount of K2CO3 andHounsfield
unit.
inside the plugs from the first color of eachmaterial to amore yellowish
tinge. The time required for the cooling process was about 30 min.
Requirement of a hybridMR/CT-compatible
phantom
The suggested requirements for the hybridMR/CT-compatible phan-
tom are: (1) tissue-equivalent relaxation times of MR images and HU
of CT images, (2) dielectric properties for MR, (3) homogeneous
relaxation times andHU, (4) sufficient strength to fabricate a torso, (5)
ease of handling, (6) chemical and physical stability over an extended
time, and (7) can be used for a wide variety of tissue-equivalent mate-
rials. Half of the first requirement was achieved because the tissue-
equivalent material for CT images was successfully developed in con-
trast to the results from MR images. The second requirement could
not be investigated in this study. However, the reference research that
we followed has demonstrated that the dielectric properties for MR
were achieved [32, 33]. The third requirement was also fulfilled for
CT images in contrast with the requirement for MR images. The fifth
requirement was achieved because of the lightweight feature of the
developed phantom due to the weight of the 2D dosimetric mea-
surement equipment for the QA and Catphan phantoms (Phantom
Laboratory, Salem, NY, USA), which is the standard phantom for QA
for CT images in radiation oncology departments in most hospitals,
and ranges from 7 to 33 kg [41, 42]. Next, the stability of the devel-
oped phantom was determined as described in ‘Production of tissue-
equivalent materials’ in the Results section since the results were con-
sistent for over 4 months. The last requirement was also accomplished
bydeveloping 14different tissue-equivalentmaterials. The commercial
CT calibration phantom offers 5–7 different tissue-equivalent materi-
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Table 3. Hounsfield unit, signal intensity and T1 and T2 relaxation times of tissue-equivalent material for each organ (group 1).
The signal intensity was calculated based on theMR image by applying the scan parameters for the axial plane as follows: slice
thickness, 10mm;matrix, 256× 256; field of view, 220mm; bandwidth,± 15.63 kHz; and number of acquisitions, 1 with TR 10
000ms, TE 69ms.













Muscle 5.87 327.81 1420.00 1436.00 −1.11% 32.00 35.41 −9.63%
White
matter
0.95 1006.29 832.00 792.70 4.96% 80.00 84.2 −4.99%
Gray
matter
2.29 973.98 1820.00 1868.00 −2.57% 99.00 90.5 9.39%
Liver 1.85 549.27 812.00 860.00 −5.58% 42.00 42.39 −0.92%
Liver 1.56 409.71 809.00 841.00 −3.80% 34.00 38.67 −12.08%
Kidney 2.07 655.72 1194.00 1270.30 −6.01% 56.00 64.54 −13.23%
Heart 2.07 643.62 1471.00 1382.00 6.44% 47.00 47.84 −1.76%
Prostate 0.62 922.35 1597.00 1561.00 2.31% 74.00 82.1 −9.87%
Spinal cord −3.15 953.68 993.00 989.00 0.40% 78.00 86.6 −9.93%
Bone
marrow
−1.54 679.68 586.00 595.30 −1.56% 49.00 55.69 −12.01%
Breast fat −3.46 1013.94 367.00 344.50 6.53% 53.00 56.6 −6.36%
Pancreas 1.51 576.83 725.00 758.40 −4.40% 43.00 43.18 −0.42%
Air −993.15 1338.00
Water 3.88 7.00
Fig. 4. Fourteen different developed tissue-equivalent materials (left) and its MR image for each plug listed in Table 1 with TR 15
000ms, TE 15ms. 1White matter, 2 gray matter 3muscle, 4 liver-1, 5 liver-2, 6 kidney, 7 heart, 8 prostate, 9 spinal cord, 10, water
11 bonemarrow, 12 pancreas, 13–14 breast fat. The air plug listed in Table 1 is not shown in this figure. Number 14 plug was
replaced with an air plug in the final experiment.)
Dosimetric evaluation
Dosimetric results for the converted MR image set was evaluated by
comparing dose distribution from the CT image. The percentage dif-
ference of each sample for average dose was calculated. The percentage
difference ranged from −0.76 to 0.37%. Differences in dose distribu-
tion fromCT andMR images are illustrated in Fig. 5. The relative dose
scale on thefigurewas selected tobe from−5 to5% formaximumdose.
DISCUSSION
A hybrid MR/CT-compatible phantom for use in the radiation
oncology field was designed for MR-only radiotherapy, allowing full
application of MR images, including image target delineation and
radiation dose calculation without the use of CT. We have aimed to
demonstrate that the relation between MR and CT could be directly
applied in a conventional TPS because conversion from the SI on MR
to HU or RED was possible by using a CT conversion table instead
of HU to RED, which can be easily adopted in the clinic. We expect
that during operation of an MR-only treatment facility, each clinic
would be able to establish a conversion table using MR and CT of the
developed phantom and periodically perform QA for the conversion
process. To our knowledge, this study was the first trial to design and
suggest amethod for the development of a hybridMR/CT-compatible
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Fig. 5. Dose difference fromCT andMR image-based dose distribution. Two slice images were selected and the relative dose scale
on the figure was selected from−5,−4,−3,−2,−1, 0, 1, 2, 3, 4, 5% for maximum dose.
Table 4. Dosimetric result for each sample fromCT and convertedMR image set. Dose–volume histogram of each sample ROI
was utilized andD99% andD1% were the doses for 99% and 1% of the volume displayed on the cumulative dose volume histogram,
which were considered theminimum andmaximum doses for each ROI






Average D99% D1% Average D99% D1%
Muscle 690 643 717 690 642 717 0.00%
White matter 664 620 693 664 620 693 0.00%
Gray matter 469 407 579 468 406 579 0.21%
Liver 529 484 577 530 485 577 −0.19%
Liver 667 624 697 667 624 697 0.00%
Kidney 598 538 641 598 538 641 0.00%
Heart 652 609 681 652 607 681 0.00%
Prostate 528 479 618 532 476 619 −0.76%
Spinal cord 654 608 686 654 608 686 0.00%
Bone
marrow
684 654 709 684 654 708 0.00%
Breast fat 536 483 620 536 482 620 0.00%
Pancreas 528 476 620 528 475 618 0.00%
Air 0 0 0 0 0 0 0.00%
Water 561 485 574 560 483 574 0.18%
such as treatment planning for the contouring process and generating
electron density information. The suggested requirements for the
hybrid MR/CT-compatible phantom described in the Results section
were mostly met in this study, with some exceptions. These aspects
will be discussed below. Furthermore, design and production of the
whole phantom was successfully conducted in this study.
Modulation of CT images by adding K2Co3 was successfully
demonstrated in our study. The amount of K2CO3 required to produce
tissue-equivalent materials for CT images was determined, which
was described in equation (3). Additionally, the effect of K2CO3 on
MR images was investigated, and no considerable effect was found
for MR images since all of the measurement data from group 2 were
acceptable for modulation of MR images by adding K2CO3, with a
5% percentage difference tolerance (Table 2). However, one of the
limitations of this research is that the production technique that used
mixed chemical components to make tissue-equivalent materials for
MR and CT images has limitations for utilization during MR-only
radiation treatment at certain anatomical sites. Since adding chemical
components into distilled water could increase the physical density to
>1, this increment can directly produce an HU value >0. Certain
anatomical sites, especially air regions that have an HU value <0,
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the most important component of MR-guided RT is the superior soft
tissue contrast of MR images to clinically verify the tumor region and
organs at risk (OARs), the limitation in terms of the air region could be
overcome by applying this method to non-air region sites, especially
the brain and abdomen. These brain and abdomen sites, except in
the upper part of the liver, are filled with soft tissue that mostly lacks
air regions due to the introduction of magnetic field distortion at
tissue–air interfaces [4, 10, 23]. These clinical sites could maximize
the advantage of RT usingMR images for the reasons described above.
Furthermore, liver cancer is one of the main targeted cancer types that
emphasize the major advantage of MR-only radiation treatment. MR
images were able to distinguish the specific differences in liver tissue,
and our reference data were used to develop andmeasure two different
liver tissues with various chemical compositions. Thus, we used two
different compositions of tissue-equivalent materials on MR images
(Table 1).
The SI from MR images could not be compared with the HU
values from CT images based on the same tissue-equivalent material
because of differently measured T1 and T2 data compared with the
reference study (Table 3). As described in the Results section, the T1
and T2measurement data were compared with reference data, and the
average percentage differences were 0.37 and 5.98% for the T1 and
T2 relaxation times, respectively. Themaximum percentage difference
was 13.23% of kidney for the T2 relaxation time, and the minimum
percentagedifferencewas 0.40%of the spinal cord for theT1 relaxation
time. According to the 5% percentage difference tolerance (Table 3),
11measurement sites among 24were determined to be acceptable, and
the tissue-equivalent materials for the liver were acceptable as tissue-
equivalentmaterials. The tissue-equivalentmaterials that showed>5%
difference also showed a small amount of difference in absolute value.
For example, the highest percentage difference was observed from
kidney and liver samples for T2 relaxation time and the absolute dif-
ferences of those sample was 8.54 and 4.67 for T2 relaxation time,
whereas the percentage difference of the same samples was 13.23 and
12.08%, respectively. This result could be due to several reasons. First,
the geometry of the developed phantom could be the reason for the
disagreement between the T1 andT2 measurements and reference
data. Each plug in the developed phantom was placed ∼19–22 mm
from the next plugwith regular spacing to avoid artifacts onCT images,
and plugs containing high-density materials were evenly distributed.
On the other hand, compared with our study, the plug was muchmore
closely arranged in the reference study, which focused on the develop-
ment of tissue-equivalent materials only for MR images. Furthermore,
the diameter of each plug in the reference study was 40 mm, whereas
that in our study was 37 mm. Thus, different geometrical information
could affect the disagreement between the reference data and T1 and
T2measurements in our study. However, the space between each plug
and the diameters of the phantom and each plug used in our studywere
inevitable choices since the external diameter of the developed phan-
tomwas restricted to∼180mmbecause it was located inside the head-
coil for MR image acquisition. In addition, the space between each
plugwas selected to avoid possible artifacts onCT images, as described
above. Therefore, the diameter of the phantom and plug inserted in
the phantom and its location inside the phantom were restricted to
be equal to those of the reference study, thus leading to the disagree-
ment in the T1 and T2 measurements. Another possible reason for
the disagreement in the T1 and T2 measurement data was the use of
different machines for MR image acquisition. Several previous studies
have suggested that MRmachines have a variety of differences for MR
images depending on the manufacturer, although most of the input
parameters for acquisition of MR images can be specifically chosen.
Although almost all possible input parameters were applied in ourMR
experiment, the different equipment and manufacturers used for the
MR experiment could cause disagreement in the T1 and T2 relaxation
times. Thus, the development of tissue-equivalent materials for MR
images requires further research, and differences can be minimized by
considering the above results.
The scan parameter in our study could be useful to measure the
proton density (TE: 15 ms, TR: 15 000 ms, short TE to minimize T2
losses, and a long TR to minimize T1 losses), which could represent
the percentage of proton concentration in water and the intensity of
the MR image could be proportional to proton density [45]. Thus,
the proton density using tissue-equivalentmaterials was acquired and a
standardization process of the developedphantomwithout sequencing
technique was performed unless short TE, long TR does not widely
apply in the clinic.
Dosimetric evaluation was performed using CT and MR images
with group 1 tissue-equivalentmaterials (Table 4). Themaximumper-
centage differences of dosimetric results using the CT and converted
MR image set of the developed phantom was −0.76%. Since the HU
value of CT and the SI value of MR are not in fact in a linear relation-
ship, it is difficult to predict the exact conversion process for overlap-
ping parts. Therefore, in this study, in order to consider the continuity
of the SI value of the MR image and to minimize the missing SI value
or voxel in the conversion process, the conversion method is designed
to convert the SI value of a specific section into a single HU value.
In this process, the SI values of 100–380, 380–430, 430–560, 560–
670, 670–960, 960–980, 980–1200 and 1200–1400 were converted to
the HU values of 30, 15, 60, 0, 30, 60, 35 and 45. A certain range of
SI values was determined to reduce the overlapping part as much as
possible and one single HU value to SI conversion was determined by
reference data [44, 46]. Furthermore, this range could be classified by
treatment site. By developing various conversion structures depending
on treatment sites, it is expected tominimize the overlapping SI section
by distinguishing organs located far apart in the same human body. In
summary, dose distribution from CT and MR phantom images could
not demonstrate dosimetric effect and inhomogeneous distribution of
SI value on MR images. However, this final dosimetric result could
represent the application of equation (3) to tissue-equivalentmaterials
to modulate HU value and application of the converted MR image set
to a commercialized TPS. From this study, the feasibility of the devel-
opment of tissue-equivalent materials on both CT and MR images in
a hybrid phantom was confirmed. Thus, the inhomogeneity of MR
images for the human body and the conversion process from MR to
CT image, with consideration of the non-linear relationship between
CT andMR, is required as a further study.
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